Braun Stacey Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $13M | Sell |
|
|||||
|
2024
Q4 | $15.3M | Sell |
|
|||||
|
2024
Q3 | $23.3M | Sell |
|
|||||
|
2024
Q2 | $24.5M | Sell |
|
|||||
|
2024
Q1 | $22.5M | Buy |
|
|||||
|
2023
Q4 | $18.9M | Buy |
|
|||||
|
2023
Q3 | $17.3M | Buy |
|
|||||
|
2023
Q2 | $15.1M | Sell |
|
|||||
|
2023
Q1 | $32.2M | Buy |
|
|||||
|
2022
Q4 | $14M | Sell |
|
|||||
|
2022
Q3 | $13.5M | Buy |
|
|||||
|
2022
Q2 | $9.57M | Sell |
|
|||||
|
2022
Q1 | $14.9M | Sell |
|
|||||
|
2021
Q4 | $13.9M | Buy |
|
|||||
|
2021
Q3 | $13.3M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $9.76M | Buy |
|
|||||
|
2016
Q3 | $10.2M | Buy |
|
|||||
|
2016
Q2 | $8.15M | Sell |
|
|||||
|
2016
Q1 | $9.1M | Sell |
|
|||||
|
2015
Q4 | $16.9M | Buy |
|
|||||
|
2015
Q3 | $9.07M | Buy |
|